Eisai

Organization

Japanese pharmaceutical company co-developing lecanemab with Biogen

3 stories

Experimental Drug Shows First-Ever Reduction in Tau Pathology and Cognitive Benefit in Early Alzheimer's Trial

Researchers Find Boosting Single Protein May Help Brain Fight Alzheimer's Disease

Study Concludes Anti-Amyloid Alzheimer's Drugs Have No Clinically Meaningful Effect